New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

For men after 50, regular medical tests, including PSA (prostate-specific antigen), are a necessity. And that’s what saved ...

Chandigarh: Observing that a medical practitioner or hospital would be liable only where their conduct fell below the ...

Cervical cancer treatment evolves with molecular screening and immunotherapies, emphasizing early detection as key to ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

New report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given before surgery ...

Lung tumoroids as a testing platform for precision CAR T-cell therapy. Nature Biomedical Engineering (2025). DOI: 10.1038/s41551-025-01594-3 ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

New data from the American Cancer Society shows major progress in cancer survival, with nearly 70% of people now living at ...

To cut to the chase, I was struggling to pee. I’d never had issues with this before, and an odd, alarming new ritual was ...

The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...

Full-year (FY) 2025 unaudited Group revenue of approximately US$804 million (A$1.2 billion 1 ), in line with upgraded guidance of US$800-$820 million 2 (previously US$770-800 million). Q4 2025 ...